Rare lephants
Screener

Acumen Pharmaceuticals, Inc.

ABOS ·Healthcare, Drug Manufacturers - General, United States
Financial Statements › SEC Filings

SEC Filings

Form Filed Description
SC 13G/A Feb 14, 2023
8-K Feb 1, 2023 8-K
4 Jan 18, 2023 FORM 4 SUBMISSION
4 Jan 18, 2023 FORM 4 SUBMISSION
4 Jan 18, 2023 FORM 4 SUBMISSION
4 Jan 18, 2023 FORM 4 SUBMISSION
4 Jan 18, 2023 FORM 4 SUBMISSION
4 Jan 4, 2023 FORM 4 SUBMISSION
3 Jan 4, 2023 FORM 3 SUBMISSION
8-K Jan 4, 2023 8-K
4 Jan 3, 2023 FORM 4 SUBMISSION
10-Q Nov 14, 2022 10-Q
8-K Nov 14, 2022 8-K
8-K Oct 24, 2022 8-K
SC 13G/A Oct 7, 2022
8-K Sep 12, 2022 8-K
4 Sep 7, 2022 FORM 4 SUBMISSION
3 Sep 7, 2022 FORM 3 SUBMISSION
10-Q Aug 15, 2022 10-Q
8-K Aug 15, 2022 8-K
8-K Aug 1, 2022 8-K
EFFECT Jul 8, 2022
CORRESP Jul 6, 2022
UPLOAD Jul 6, 2022
S-3 Jul 1, 2022 S-3
← Newer Page 11 of 15 · 365 filings Older →